SCHEMBL22100543

SCHEMBL22100543

CCOC(=O)c1ccc(NC(=O)CCCl)c(NC(=O)CCCl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ GAA P10253 2/20 0.49
▸ CYP1A2 P05177 2/20 0.48
▸ PTGER4 P35408 4/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA7 P43166 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ MAPT P10636 4/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ PKM P14618 1/20 0.47
▸ CRHBP P24387 1/20 0.47
▸ CRHR2 Q13324 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22075835 0.87 ALDH1A1 (0.58) KDM4EKMT2AMAPTALDH1A1PKM
SCHEMBL29195725 0.82 SMN1; SMN2 (0.56) RAB9ANPC1KDM4ESMN1; SMN2GAA
SCHEMBL10953580 0.76 RAB9A (0.47) RAB9ANPC1KDM4ESMN1; SMN2GAA
SCHEMBL15971476 0.76 HSD17B2 (0.58) RAB9ANPC1KDM4ESMN1; SMN2GAA
SCHEMBL6171410 0.76 ALDH1A1 (0.63) RAB9ANPC1KDM4ESMN1; SMN2GAA
SCHEMBL22833162 0.75 ALDH1A1 (0.54) RAB9ANPC1KDM4ESMN1; SMN2KMT2A
SCHEMBL22114012 0.75 ALDH1A1 (0.48) KDM4EGAAKMT2AMAPTALDH1A1
SCHEMBL5739672 0.74 MTNR1A (0.38) RAB9ANPC1KDM4ESMN1; SMN2GAA
SCHEMBL19003293 0.74 CA12 (0.57) RAB9ANPC1KDM4ESMN1; SMN2CYP1A2
SCHEMBL6171237 0.73 PTGER4 (0.62) RAB9ANPC1KDM4EGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894416-B1 FERROPORTIN INHIBITORS AND METHODS OF USE GLOBAL BLOOD THERAPEUTICS INC (US) 2022-11-09 — — EP disclosed
WO-2020123850-A1 FERROPORTIN INHIBITORS AND METHODS OF USE GLOBAL BLOOD THERAPEUTICS, INC. (US) 2020-06-18 — — WO disclosed
Send feedback